| Oct 23 2024 |
Over 940,000 Medicare Beneficiaries Impacted by Data Breach |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 23 2024 |
Deadlines Approaching for New ACA Section 1557 Nondiscrimination Requirements: Action Items for Covered Group Health Plans |
Proskauer Rose LLP |
| Oct 23 2024 |
Employment Law This Week Episode 365 - Mental Health Parity Rules, NLRB Restrictions, New York's Workplace Violence Prevention Law [Video, Podcast] |
Epstein Becker & Green, P.C. |
| Oct 23 2024 |
Health Plan Coverage Mandate for Over-the-Counter Contraception Proposed by Biden Administration |
Jackson Lewis P.C. |
| Oct 22 2024 |
Cyber Vigilance: $300K Resolution Paid, Almost $900K in Costs Waived for Government Contractor Data Breach |
Tycko & Zavareei LLP |
| Oct 22 2024 |
EPA Issues Final Lead and Copper Rule Improvements with Far Reaching Lead Pipe Replacement Mandates |
Beveridge & Diamond PC |
| Oct 22 2024 |
Can Republicans Repeal the Inflation Reduction Act (IRA)? |
Womble Bond Dickinson (US) LLP |
| Oct 22 2024 |
Madam Policy: Trailblazing Tattoo Artist Friday Jones: Empowering Breast Cancer Survivors Through Art [Podcast] |
Bracewell LLP |
| Oct 22 2024 |
New York Passes Bill Prohibiting Use of PFAS in “Apparel and Outdoor Apparel for Severe Wet Conditions” |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Oct 22 2024 |
Let’s Talk Compliance: Physician Compensation Plans and Recent Trends in Physician Compensation 2024 |
Foley & Lardner LLP |
| Oct 22 2024 |
Latest Updates on Per- and Polyfluorinated Substances (PFAS) – September 2024 |
Squire Patton Boggs (US) LLP |
| Oct 22 2024 |
PFAS Detection Test Thrown Out In Court – What It Teaches Us About Compliance Efforts |
CMBG3 Law |
| Oct 21 2024 |
Mental Health Parity and Addiction Equity Act Final Rules (“Final Rules”) Are Released: Plans and Issuers Must Prepare for January 1, 2025 Effective Date (US) |
Squire Patton Boggs (US) LLP |
| Oct 21 2024 |
Zafirov Decision: Federal Court Questions Constitutionality of False Claims Act’s Qui Tam Whistleblower Provisions |
Greenberg Traurig, LLP |
| Oct 21 2024 |
PFAS Litigation Update: Another Tool in the Defendants’ Toolbox |
ArentFox Schiff LLP |
| Oct 21 2024 |
Skilled Nursing Facilities Begin Planning for Mandatory Off-Cycle Revalidations |
Barnes & Thornburg LLP |
| Oct 21 2024 |
Massachusetts Sick Leave Expanded to Include Pregnancy Loss and Other Reproductive Issues |
ArentFox Schiff LLP |
| Oct 21 2024 |
Sixth Circuit Makes Bold Ruling on Issue of Disability Accommodations |
CMBG3 Law |
| Oct 18 2024 |
Supreme Court Declines to Hear “Willfulness” Case |
Polsinelli PC |
| Oct 18 2024 |
Federal District Court Rules Qui Tam Whistleblower Enforcement of False Claims Act Unconstitutional |
Polsinelli PC |
| Oct 18 2024 |
Governor Newsom Vetoes AB 3129, Addressing Private Equity in California Health Care Transactions |
Polsinelli PC |
| Oct 18 2024 |
MEDICAL DATA AT RISK?: CIPA Takes on Digital Tracking in Healthcare |
Troutman Amin, LLP |
| Oct 18 2024 |
Trending in Telehealth: October 7 – 14, 2024 |
McDermott Will & Emery |
| Oct 18 2024 |
NY Providers Take Note: New Consent to Payment Laws Effective October 20 |
McDermott Will & Emery |
| Oct 18 2024 |
FDA’s Voluntary Sodium Reduction Goals: Key Takeaways from Recent Webinar |
Keller and Heckman LLP |
| Oct 18 2024 |
Teva Pharmaceuticals Agrees to Pay $450 Million to Resolve FCA Claims |
ArentFox Schiff LLP |
| Oct 18 2024 |
FTC Finalizes Changes to Premerger Notification Form: What It Means for Healthcare Transactions |
Bradley Arant Boult Cummings LLP |
| Oct 17 2024 |
Texas-Sized Fraud: Corporate Relator Takes on Laboratory Referral Kickback Scheme |
Tycko & Zavareei LLP |
| Oct 17 2024 |
Let’s Clear The Air: Industrial Facilities Must Comply With Board Of Health Regulations |
Goulston & Storrs |
| Oct 17 2024 |
TikTok’s Legal Woes from State AGs Continues |
Robinson & Cole LLP |
| Oct 17 2024 |
This Week in 340B: October 8 – 14, 2024 |
McDermott Will & Emery |
| Oct 17 2024 |
Trending in Telehealth: September 30 – October 7, 2024 |
McDermott Will & Emery |
| Oct 17 2024 |
New DEA Rule Expected to Extend Controlled Substance Telemedicine Prescribing Flexibilities Through 2025 |
Foley & Lardner LLP |
| Oct 17 2024 |
Insulin Overpricing Lawsuits: What Patients and Families Need to Know |
Oberheiden P.C. |
| Oct 16 2024 |
A Win for Out-of-Network Providers |
Epstein Becker & Green, P.C. |
